It is currently 19 Aug 2019 03:46

All times are UTC + 5:30 hours [ DST ]




Post new topic Reply to topic  [ 1 post ] 
Author Message
 Post subject: Lung Cancer Drug for GTD
PostPosted: 06 Dec 2017 19:32 
Offline
User avatar

Joined: 26 Feb 2013 10:59
Posts: 650
A drug normally used to treat lung cancer and melanoma could also save the lives of women suffering from a rare but deadly disease after pregnancy.

A clinical trial of pembrolizumab showed that three out of four patients with cancerous gestational trophoblastic disease (GTD) went into remission. GTD forms after one in 50,000 pregnancies and requires women to have chemotherapy. Most can be cured but up to 5 per cent die. The trial, published in The Lancet, was carried out by Imperial College London and took place at Charing Cross Hospital and Karolinska University Hospital in Sweden.

Pembrolizumab stimulates the immune system to kill cancer cells. Four women were given the drug every three weeks for about six months. Up to two years on, three had no signs of cancer, although the fourth had died.


Top
 Profile Send private message  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC + 5:30 hours [ DST ]


Who is online

Users browsing this forum: No registered users and 1 guest


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum

Jump to:  
cron